1,698
Views
1
CrossRef citations to date
0
Altmetric
Articles

Platelet-leukocyte aggregate formation and inflammation in patients with pulmonary arterial hypertension and CTEPH

, , &
Pages 1199-1207 | Received 29 Sep 2021, Accepted 04 Jun 2022, Published online: 14 Jun 2022

References

  • McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009;119:2250–2294. Epub 2009/ 04/01. doi:10.1161/CIRCULATIONAHA.109.192230.
  • Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015;46:903–975. Epub 2015/ 09/01. doi:10.1183/13993003.01032-2015.
  • Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019;53:1801913. Epub 2018/12/14. doi:10.1183/13993003.01913-2018.
  • Swedish Pulmonary Arterial Hypertension Registry Annual Report. 2019. https://www.ucr.uu.se/spahr/arsrapporter/arsrapport-spahr-2020/viewdocument/148
  • Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007;30:104–109. Epub 2007/ 03/16. doi:10.1183/09031936.00092306.
  • Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, Olsson KM, Meyer K, Vizza CD, Vonk-Noordegraaf A, et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J 2017;50;1700740. Epub 2017/ 08/05. doi:10.1183/13993003.00740-2017.
  • Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994;144:275–285. Epub 1994/ 02/01.
  • Kim NH, Delcroix M, Jais X, Madani MM, Matsubara H, Mayer E, Ogo T, Tapson VF, Ghofrani HA, Jenkins DP. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2019;53:1801915. Epub 2018/12/14. doi:10.1183/13993003.01915-2018.
  • Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 2014;115:165–175. Epub 2014/ 06/22. doi:10.1161/CIRCRESAHA.113.301141.
  • Matthews DT, Hemnes AR. Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension. Pulm Circ 2016;6:145–154. Epub 2016/ 06/03. doi:10.1086/686011.
  • Bonderman D, Jakowitsch J, Adlbrecht C, Schemper M, Kyrle PA, Schonauer V, Exner M, Klepetko W, Kneussl MP, Maurer G, et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 2005;93:512–516. Epub 2005/ 03/01. doi:10.1160/TH04-10-0657.
  • Molossi S, Clausell N, Rabinovitch M. Reciprocal induction of tumor necrosis factor-alpha and interleukin-1 beta activity mediates fibronectin synthesis in coronary artery smooth muscle cells. J Cell Physiol 1995;163:19–29. Epub 1995/ 04/01. doi:10.1002/jcp.1041630104.
  • Courboulin A, Tremblay VL, Barrier M, Meloche J, Jacob MH, Chapolard M, Bisserier M, Paulin R, Lambert C, Provencher S, et al. Kruppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension. Respir Res 2011;12:128. Epub 2011/ 09/29. doi:10.1186/1465-9921-12-128.
  • Khandagale A, Aberg M, Wikstrom G, Bergstrom Lind S, Shevchenko G, Bjorklund E, Siegbahn A, Christersson C. Role of extracellular vesicles in pulmonary arterial hypertension: modulation of pulmonary endothelial function and angiogenesis. Arterioscler Thromb Vasc Biol 2020;40:2293–2309. Epub 2020/ 08/08. doi:10.1161/ATVBAHA.120.314152.
  • Marcoux G, Laroche A, Espinoza Romero J, Boilard E. Role of platelets and megakaryocytes in adaptive immunity. Platelets 2021;32:340–351. Epub 2020/ 07/01. doi:10.1080/09537104.2020.1786043.
  • Jungi TW, Spycher MO, Nydegger UE, Barandun S. Platelet-leukocyte interaction: selective binding of thrombin-stimulated platelets to human monocytes, polymorphonuclear leukocytes, and related cell lines. Blood 1986;67:629–636. Epub 1986/ 03/01. doi:10.1182/blood.V67.3.629.629.
  • Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989;59:305–312. Epub 1989/ 10/20. doi:10.1016/0092-8674(89)90292-4.
  • Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991;78:1730–1737. Epub 1991/ 10/01. doi:10.1182/blood.V78.7.1730.1730.
  • Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000;192:193–204. Epub 2000/ 07/19. doi:10.1084/jem.192.2.193.
  • Finsterbusch M, Schrottmaier WC, Kral-Pointner JB, Salzmann M, Assinger A. Measuring and interpreting platelet-leukocyte aggregates. Platelets 2018;29:677–685. Epub 2018/ 02/21. doi:10.1080/09537104.2018.1430358.
  • Loguinova M, Pinegina N, Kogan V, Vagida M, Arakelyan A, Shpektor A, Margolis L, Vasilieva E. Monocytes of different subsets in complexes with platelets in patients with myocardial infarction. Thromb Haemost 2018;118:1969–1981. Epub 2018/ 10/10. doi:10.1055/s-0038-1673342.
  • Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, Marchese P, Frelinger AL 3rd, Goldberg RJ, Michelson AD. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001;38:1002–1006. Epub 2001/ 10/05. doi:10.1016/S0735-1097(01)01485-1.
  • Schrottmaier WC, Mussbacher M, Salzmann M, Assinger A. Platelet-leukocyte interplay during vascular disease. Atherosclerosis 2020;307:109–120. Epub 2020/ 05/23. doi:10.1016/j.atherosclerosis.2020.04.018.
  • Christersson C, Johnell M, Siegbahn A. Tissue factor and IL8 production by P-selectin-dependent platelet-monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10. JThrombHaemost 2008;6:986–994. doi:10.1111/j.1538-7836.2008.02956.x.
  • Savai R, Pullamsetti SS, Kolbe J, Bieniek E, Voswinckel R, Fink L, Scheed A, Ritter C, Dahal BK, Vater A, et al. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2012;186:897–908. Epub 2012/ 09/08. doi:10.1164/rccm.201202-0335OC.
  • Gerasimovskaya E, Kratzer A, Sidiakova A, Salys J, Zamora M, Taraseviciene-Stewart L. Interplay of macrophages and T cells in the lung vasculature. Am J Physiol Lung Cell Mol Physiol 2012;302:L1014–1022. Epub 2012/ 03/06. doi:10.1152/ajplung.00357.2011.
  • Yu YA, Malakhau Y, Yu CA, Phelan SJ, Cumming RI, Kan MJ, Mao L, Rajagopal S, Piantadosi CA, Gunn MD. Nonclassical monocytes sense hypoxia, regulate pulmonary vascular remodeling, and promote pulmonary hypertension. J Immunol 2020;204:1474–1485. Epub 2020/ 01/31. doi:10.4049/jimmunol.1900239.
  • Hu XS, Du CQ, Zeng CL, Yao L, Zhang FR, Wang K, Chen JZ, Li N, Hu H. Systemic evaluation of platelet and leukocyte activation and interaction in a rat model of pulmonary arterial hypertension. Cardiology 2010;117:44–53. Epub 2010/ 10/07. doi:10.1159/000320107.
  • Li N, Goodall AH, Hjemdahl P. Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry 1999;35:154–161. Epub 1999/ 12/20. doi:10.1002/(SICI)1097-0320(19990201)35:2<154::AID-CYTO7>3.0.CO;2-Y.
  • Taguchi H, Kataoka M, Yanagisawa R, Kawakami T, Tamura Y, Fukuda K, Yoshino H, Satoh T. Platelet level as a new prognostic factor for idiopathic pulmonary arterial hypertension in the era of combination therapy. Circ J 2012;76:1494–1500. Epub 2012/ 03/27. doi:10.1253/circj.CJ-11-1223.
  • Mojadidi MK, Goodman-Meza D, Eshtehardi P, Pamerla M, Msaouel P, Roberts SC, Winoker JS, Jadeja NM, Zolty R. Thrombocytopenia is an independent predictor of mortality in pulmonary hypertension. Heart Lung 2014;43:569–573. Epub 2014/ 08/30. doi:10.1016/j.hrtlng.2014.07.006.
  • Chin KM, Channick RN, de Lemos JA, Kim NH, Torres F, Rubin LJ. Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension. Chest 2009;135:130–136. Epub 2008/ 08/23. doi:10.1378/chest.08-1323.
  • Lapa M, Acencio MM, Farias AQ, Teixeira LR, Fernandes CJ, Jardim CP, Terra-Filho M. Selectins and platelet-derived growth factor (PDGF) in schistosomiasis-associated pulmonary hypertension. Lung 2014;192:981–986. Epub 2014/ 09/15. doi:10.1007/s00408-014-9643-0.
  • Manakeng K, Prasertphol P, Phongpao K, Chuncharunee S, Tanyong D, Worawichawong S, Svasti S, Chaichompoo P. Elevated levels of platelet- and red cell-derived extracellular vesicles in transfusion-dependent beta-thalassemia/HbE patients with pulmonary arterial hypertension. Ann Hematol 2019;98:281–288. Epub 2018/ 10/20. doi:10.1007/s00277-018-3518-z.
  • Maeda NY, Carvalho JH, Otake AH, Mesquita SM, Bydlowski SP, Lopes AA. Platelet protease-activated receptor 1 and membrane expression of P-selectin in pulmonary arterial hypertension. Thromb Res 2010;125:38–43. Epub 2009/ 05/19. doi:10.1016/j.thromres.2009.04.018.
  • Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327:70–75. Epub 1992/ 07/09. doi:10.1056/NEJM199207093270202.
  • Launay JM, Herve P, Peoc’h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, et al. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 2002;8:1129–1135. Epub 2002/ 09/24. doi:10.1038/nm764.
  • Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104:1533–1537. Epub 2001/ 09/26. doi:10.1161/hc3801.095588.
  • Gerrits AJ, Frelinger AL 3rd, Michelson AD. Whole blood analysis of leukocyte-platelet aggregates. Curr Protoc Cytom 2016;78:6 15 11–16 15 10. Epub 2016/ 10/11.
  • Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, Hechtman HB, Michelson AD. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998;31:352–358. Epub 1998/ 02/14. doi:10.1016/S0735-1097(97)00510-X.
  • Zamora C, Canto E, Nieto JC, Garcia-Planella E, Gordillo J, Ortiz MA, Suarez-Calvet X, Perea L, Julia G, Juarez C, et al. Inverse association between circulating monocyte-platelet complexes and inflammation in ulcerative colitis patients. Inflamm Bowel Dis 2018;24:818–828. Epub 2018/ 03/13. doi:10.1093/ibd/izx106.
  • Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995;151:1628–1631. Epub 1995/ 05/01. doi:10.1164/ajrccm.151.5.7735624.
  • Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, Trembath RC, Jennings S, Barker L, Nicklin P, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 2010;122:920–927. Epub 2010/ 08/18. doi:10.1161/CIRCULATIONAHA.109.933762.
  • Rhodes CJ, Wharton J, Howard LS, Gibbs JS, Wilkins MR. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart 2011;97:1054–1060. Epub 2011/ 05/12. doi:10.1136/hrt.2011.224857.
  • Simpson CE, Chen JY, Damico RL, Hassoun PM, Martin LJ, Yang J, Nies M, Griffiths M, Vaidya RD, Brandal S, et al. Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension. Eur Respir J 2020;55;1901761. Epub 2020/ 02/08. doi:10.1183/13993003.01761-2019.
  • Cracowski JL, Chabot F, Labarere J, Faure P, Degano B, Schwebel C, Chaouat A, Reynaud-Gaubert M, Cracowski C, Sitbon O, et al. Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension. Eur Respir J 2014;43:915–917. Epub 2013/ 11/16. doi:10.1183/09031936.00151313.
  • Tamosiuniene R, Tian W, Dhillon G, Wang L, Sung YK, Gera L, Patterson AJ, Agrawal R, Rabinovitch M, Ambler K, et al. Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension. Circ Res 2011;109:867–879. Epub 2011/ 08/27. doi:10.1161/CIRCRESAHA.110.236927.
  • Ed Rainger G, Chimen M, Harrison MJ, Yates CM, Harrison P, Watson SP, Lordkipanidze M, Nash GB. The role of platelets in the recruitment of leukocytes during vascular disease. Platelets 2015;26:507–520. Epub 2015/ 07/22. doi:10.3109/09537104.2015.1064881.
  • da Costa Martins P, van den Berk N, Ulfman LH, Koenderman L, Hordijk PL, Zwaginga JJ. Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation. Arterioscler Thromb Vasc Biol 2004;24:193–199. Epub 2003/ 11/15. doi:10.1161/01.ATV.0000106320.40933.E5.
  • Kuckleburg CJ, Yates CM, Kalia N, Zhao Y, Nash GB, Watson SP, Rainger GE. Endothelial cell-borne platelet bridges selectively recruit monocytes in human and mouse models of vascular inflammation. Cardiovasc Res 2011;91:134–141. Epub 2011/ 02/03. doi:10.1093/cvr/cvr040.
  • Schulz C, von Bruhl ML, Barocke V, Cullen P, Mayer K, Okrojek R, Steinhart A, Ahmad Z, Kremmer E, Nieswandt B, et al. EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall. J Thrombosis Haemostasis 2011;9:1007–1019. Epub 2011/ 02/16. doi:10.1111/j.1538-7836.2011.04235.x.
  • Tamura Y, Phan C, Tu L, Le Hiress M, Thuillet R, Jutant EM, Fadel E, Savale L, Huertas A, Humbert M, et al. Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension. J Clin Invest 2018;128:1956–1970. Epub 2018/ 04/10. doi:10.1172/JCI96462.
  • Huang Z, Liu Z, Luo Q, Zhao Z, Zhao Q, Zheng Y, Xi Q, Tang Y. Glycoprotein 130 inhibitor ameliorates monocrotaline-induced pulmonary hypertension in rats. Can J Cardiol 2016;32:1356 e1351–1356 e1310. Epub 2016/ 10/30. doi:10.1016/j.cjca.2016.02.058.